Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Five Alcohol Stocks Hedge Funds Like

Page 1 of 2

“There’s a reason you see people in yoga pants all over New York City—not because they’re working out. It’s this idea that a kind of health and well-being is the new premium,” says Valerie Toothman, vice president for marketing innovation at Anheuser-Busch InBev (NYSE:BUD). As consumers are shifting towards a healthier lifestyle, big beverage companies are looking to keep up with their tastes. By using healthy-sounding names and nutrition labels, they are trying to spin alcoholic beverages as more fitness-chic. So let’s have a look at five alcohol stocks that hedge funds are betting on.

While there are many metrics that investors can assess in the investment process, hedge fund sentiment is something that is often overlooked. However, hedge funds and other institutional investors allocate significant resources while making their bets and their long-term focus makes them the perfect investors to emulate. This is supported by our research, which determined that following the small-cap stocks that hedge funds are collectively bullish on can help a smaller investor beat the S&P 500 by around 95 basis points per month (see more details here).

alcohol-586322_1280

#5 Diageo plc (ADR) (NYSE:DEO)

-Number of Hedge Fund Holders (as of June 30): 18

-Concentration (as of June 30): 1.3%

First up is Diageo, the British maker of spirits and beer. Hedge fund interest in this stock cooled down a bit during the second quarter, with the number of long positions having inched down to 18 at the end of June from 19 registered three months earlier. Tom Gayner‘s Markel Gayner Asset Management is among the funds betting big on Diageo plc (ADR) (NYSE:DEO), having reported ownership of 1.3 million shares worth $147 million at the end of the quarter. In the most recent quarter, the company returned to growth, as the effects of the pound devaluation and a change in accounting practices in Asia have hurt the final figures. In July, Diageo plc (ADR) (NYSE:DEO) reported its financial results for the fiscal 2016, posting a net profit of £2.24 billion ($2.94 billion), down by 5.8% year-over-year. However, organic sales were up by 2.6%, while organic volume increased by 1.3%. One of the aspects that still keeps investors on their toes is how Brexit is going to affect the company’s business. Diageo’s management said it is holding talks with the government to find ways to maintain access to markets it serves.

Follow Diageo Plc (NYSE:DEO)
Trade (NYSE:DEO) Now!

#4 Ambev SA (ADR) (NYSE:ABEV)

-Number of Hedge Fund Holders (as of June 30): 21

-Concentration (as of June 30): 0.6%

Next up is Ambev, the Brazilian beverage company that has a wide beverage portfolio on top of spirits. According to our data, 21 of the funds we follow had this stock in their equity portfolio at the end of the second quarter, down from 24 a quarter before. Billionaire Ken Fisher is still bullish on Ambev SA (ADR) (NYSE:ABEV), having increased his fund’s holding of the stock by 8% to 23.7 million shares worth $138 million at the end of June. After a massive slide in 2015, Ambev stock started 2016 on the right foot and has been in an uptrend ever since, managing to advance 45% through yesterday’s closing price of $6.24 per share. The company has market cap of $95 billion and pays an annual dividend of $0.04 per share, providing investors with a 0.64% yield. Ambev SA (ADR) (NYSE:ABEV) shares are currently changing hands at a trailing Price to Earnings (P/E) ratio of 26, which is larger than the industry average P/E of 8.

Turn the page to have a look at the top 3 stocks smart money has invested in.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!